Group B streptococcus intrapartum prophylaxis guidelines adherence: A perinatal risk management issue

Journal of Perinatal and Neonatal Nursing

Volumn 24, Issue 2, 2010, Pages 100-103

  Hanson, Lisa ^a   Vandevusse, Leona ^a  

^a MARQUETTE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC PROPHYLAXIS; ARTICLE; DISEASE TRANSMISSION; FEMALE; HUMAN; MASS SCREENING; METHODOLOGY; NEWBORN; NEWBORN NURSING; NURSING; ORGANIZATION AND MANAGEMENT; PATIENT SELECTION; PERINATAL CARE; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATION; PUBLIC HEALTH SERVICE; RISK MANAGEMENT; STANDARD; STATISTICS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; UNITED STATES; VERTICAL TRANSMISSION;

ANTIBIOTIC PROPHYLAXIS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); FEMALE; GUIDELINE ADHERENCE; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MASS SCREENING; NEONATAL NURSING; PATIENT SELECTION; PERINATAL CARE; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK MANAGEMENT; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; UNITED STATES;

EID: 77951996566     PISSN: 08932190     EISSN: None     Source Type: Journal    
DOI: 10.1097/JPN.0b013e3181da2fc6     Document Type: Article

References (26)

1. Center for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Morb Mortal Wkly Rep. 2002; 51 (RR-11) : 1-22.
2. Philipson EH, Palermino DA, Robinson A. Enhanced antenatal detection of group B streptoccoccus colonization. Obstet Gynecol. 1995; 85: 437-439.
3. Smaill FM. Intrapartum antibiotics for group B streptococcal colonisation. Cochrane Database Syst Rev. 2000; (2) : CD000115. doi: 10.1002/14651858. CD000115.
4. Gilbert R. Prenatal screening for group B streptococcal infection: gaps in the evidence. Int J Epidemiol. 2003;33(1):2-8.
5. Phares CR, Lynfield R, Farley MM, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA. 2008; 299: 2056-2065. (Pubitemid 351656587)
6. Apgar BS, Greenberg G, Yen G. Prevention of group B streptococcal disease in the newborn. Am Fam Phys. 2005;71(5):903-910.
7. Yancey MK, Schuchat A, Brown LK, Ventura VL, Markenson GR. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol. 1996;88(5):811-815.
8. Puopolo KM, Madoff LC, Eichenwald EC. Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics. 2005;115(5):1240-1246.
9. Persson K, Christensen KK, Christensen P, Forsgren A, Jorgensen C, Persson PH. Asymptomatic bacteriuria during pregnancy with special reference to group B streptococci. Scand J Infect Dis. 1985; 17: 195-199.
10. Bolton M, Van Der Straten A, Cohen CR. Probiotics: potential to prevent HIV and sexually transmitted infections in women. Sex Transm Infect. 2008;35(3):214-225.
11. Hickmann ME, Rench MA, Ferrieri P, Baker CJ. Changing epidemiology of group B streptococcal colonization. Pediatrics. 1999; 104: 203-209.
12. Dillon HC, Gray E, Pass MA, Gray BM. Anorectal and vaginal carriage of group B streptococci during pregnancy. J Infect Dis. 1982;145(6):794-799.
13. Turow J, Spitzer AR. Group B streptococcal infection early onset disease controversies in prevention guidelines, and management strategies for the neonate. Clin Pediatr. 2000; 39: 317-326.
14. Bland ML, Vermillion ST, Soper DE, Austin M. Antibiotic resistance patterns of group B streptococci in late thirdtrimester rectovaginal cultures. Am J Obstet Gynecol. 2001; 184: 1125-1126.
15. Heelan JS, Hasenbein ME, McAdam AJ. Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin. J Clin Microbiol. 2004;42(3):1263-1264.
16. Pearlman MD, Pierson CL, Faix RG. Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin. Obstet Gynecol. 1998; 92: 258-261.
17. Chohan L, Hollier LM, Bishop K, Kilpatrick CC. Patterns of antibiotic resistance among group B streptococcus isolates: 2001-2004. Infect Dis Obstet Gynecol. 2006; 2006: 57492.
18. Colombo DF, Lew JL, Pedersen CA, Johnson JR, Fan-Havard P. Optimal timing of ampicillin administration to pregnant women for establishing bactericidal levels in the prophylaxis of Group B Streptococcus. Am J Obstet Gynecol. 2006; 194: 466-470.
19. Illuzzi JL, Bracken MB. Duration of intrapartum prophylaxis for neonatal group B streptococcal disease: a systematic review. Obstet Gynecol. 2006;108(5):1254-1265.
20. Bloom SL, Cox SM, Bawdon RE, Gilstrap LC. Ampicillin for neonatal group B streptococcal prophylaxis: how rapidly can bactericidal concentrations be achieved? Am J Obstet Gynecol. 1996; 175: 974-976.
21. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY. Infectious diseases: bacterial infections. In: Williams Obstetrics. 23rd ed. New York, NY: McGraw Hill; 2010: 1220-1223.
22. Bromberger P, Lawrence JM, Braun D, Saunders B, Contreras R, Petitti DB. The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcus infection in term infants. Pediatrics. 2000;106(2):244-250.
23. Bedford Russell AR, Murch SH. Could peripartum antibiotics have delayed health consequences for the infant? BJOG. 2006; 113: 758-765.
24. Pinto NM, Soskolne EI, Pearlman MD, Faix RG. Neonatal early-onset group B streptococcal disease in the era of intrapartum chemoprophylaxis: residual problems. J Perinatol. 2003; 23: 265-271.
25. Picard FJ, Bergeron MG. Laboratory detection of group B Streptococcus for prevention of perinatal disease. Eur J Clin Microbiol Infect Dis. 2004; 23: 665-671.
26. Larsen JW, Sever JL. Group B Streptococcus and pregnancy: a review. Am J Obstet Gynecol. 2008;198(4):440-450.